Global Thyroid Gland Disorders Treatment Industry Research Report Growth Trends and Competitive Analysis 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 168

Report ID: 17937

In the last several years, global market of Thyroid Gland Disorders Treatment developed stable, with an average growth rate of 4.53% during 2013 to 2018. In 2018, global revenue of Thyroid Gland Disorders Treatment is nearly 2.74 Billion USD.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers: (we can also add the other companies as you want)
AbbVie
Merck KGaA
Lannett Company
Mylan
Allergan
Pfizer
Novartis
GlaxoSmithKline
Abbott Laboratories
Sanofi

Market Segment by Product Type
Hypothyroidism
Hyperthyroidism

Market Segment by Application
Hospitals
Clinics
Other

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Middle East
Africa



Table of Contents

1 REPORT OVERVIEW 1
1.1 RESEARCH SCOPE 1
1.2 MAJOR MANUFACTURERS COVERED IN THIS REPORT 2
1.3 MARKET SEGMENT BY TYPE 3
1.3.1 Global Thyroid Gland Disorders Treatment Market Size Growth Rate by Type 3
1.3.2 Hypothyroidism 4
1.3.3 Hyperthyroidism 4
1.4 MARKET SEGMENT BY APPLICATION 5
1.4.1 Global Thyroid Gland Disorders Treatment Market Share by Application (2018-2025) 5
1.4.2 Hospitals 6
1.4.3 Clinics 6
1.4.4 Others 7
1.5 STUDY OBJECTIVES 7
1.6 YEARS CONSIDERED 8
2 GLOBAL GROWTH TRENDS 9
2.1 GLOBAL THYROID GLAND DISORDERS TREATMENT MARKET SIZE 9
2.1.1 Global Thyroid Gland Disorders Treatment Revenue 2013-2025 9
2.1.2 Global Thyroid Gland Disorders Treatment Sales 2013-2025 10
2.2 THYROID GLAND DISORDERS TREATMENT GROWTH RATE BY REGIONS 10
2.2.1 Global Thyroid Gland Disorders Treatment Sales by Regions 2013-2018 11
2.2.2 Global Thyroid Gland Disorders Treatment Revenue by Regions 2013-2018 13
2.3 INDUSTRY TRENDS 14
2.3.1 Market Top Trends 14
2.3.2 Market Drivers 15
2.3.3 Market Challenges 15
2.3.4 Porter’s Five Forces Analysis 15
3 MARKET SHARE BY MANUFACTURERS 17
3.1 THYROID GLAND DISORDERS TREATMENT SALES BY MANUFACTURERS 17
3.1.1 Thyroid Gland Disorders Treatment Sales by Manufacturers 2017-2018 17
3.1.2 Thyroid Gland Disorders Treatment Sales Market Share by Manufacturers 2017-2018 17
3.2 REVENUE BY MANUFACTURERS 19
3.2.1 Thyroid Gland Disorders Treatment Revenue by Manufacturers (2017-2018) 19
3.2.2 Thyroid Gland Disorders Treatment Revenue Share by Manufacturers (2017-2018) 19
3.2.3 Global Thyroid Gland Disorders Treatment Market Concentration Ratio 21
3.3 THYROID GLAND DISORDERS TREATMENT PRICE BY MANUFACTURERS 21
3.4 KEY MANUFACTURERS THYROID GLAND DISORDERS TREATMENT PLANTS/FACTORIES DISTRIBUTION AND AREA SERVED 22
3.5 ESTABLISHED DATE OF KEY MANUFACTURERS 23
3.6 KEY MANUFACTURERS THYROID GLAND DISORDERS TREATMENT PRODUCT OFFERED 23
3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS 24
4 MARKET SIZE BY TYPE 26
4.1 SALES AND REVENUE FOR EACH TYPE 26
4.1.1 Hypothyroidism Sales and Revenue (2013-2018) 26
4.1.2 Hyperthyroidism Sales and Revenue (2013-2018) 26
4.2 GLOBAL THYROID GLAND DISORDERS TREATMENT SALES MARKET SHARE BY TYPE 27
4.3 GLOBAL THYROID GLAND DISORDERS TREATMENT REVENUE MARKET SHARE BY TYPE 28
4.4 THYROID GLAND DISORDERS TREATMENT PRICE BY TYPE 30
5 MARKET SIZE BY APPLICATION 31
5.1 OVERVIEW 31
5.2 GLOBAL THYROID GLAND DISORDERS TREATMENT SALES BY APPLICATION 31
6 NORTH AMERICA 33
6.1 NORTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COMPANY 34
6.2 NORTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY TYPE 35
6.3 NORTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION 36
6.4 NORTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COUNTRIES 37
6.4.1 North America Thyroid Gland Disorders Treatment Sales by Countries 37
6.4.2 North America Thyroid Gland Disorders Treatment Revenue by Countries 39
6.4.3 United States 40
6.4.4 Canada 41
6.4.5 Mexico 42
7 EUROPE 43
7.1 EUROPE THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COMPANY 44
7.2 EUROPE THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY TYPE 46
7.3 EUROPE THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION 47
7.4 EUROPE THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COUNTRIES 48
7.4.1 Europe Thyroid Gland Disorders Treatment Sales by Countries 48
7.4.2 Europe Thyroid Gland Disorders Treatment Revenue by Countries 49
7.4.3 Germany 51
7.4.4 France 52
7.4.5 UK 53
7.4.6 Italy 54
7.4.7 Russia 55
8 ASIA PACIFIC 56
8.1 ASIA PACIFIC THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COMPANY 57
8.2 ASIA PACIFIC THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY TYPE 58
8.3 ASIA PACIFIC THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION 59
8.4 ASIA PACIFIC THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COUNTRIES 61
8.4.1 Asia Pacific Thyroid Gland Disorders Treatment Sales by Countries 61
8.4.2 Asia Pacific Thyroid Gland Disorders Treatment Revenue by Countries 62
8.4.3 China 64
8.4.4 Japan 65
8.4.5 Korea 66
8.4.6 India 67
8.4.7 Southeast Asia 68
9 CENTRAL & SOUTH AMERICA 69
9.1 CENTRAL & SOUTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COMPANY 70
9.2 CENTRAL & SOUTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY TYPE 71
9.3 CENTRAL & SOUTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION 72
9.4 CENTRAL & SOUTH AMERICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COUNTRIES 73
9.4.1 Central & South America Thyroid Gland Disorders Treatment Sales by Countries 73
9.4.2 Central & South America Thyroid Gland Disorders Treatment Revenue by Countries 74
9.4.3 Brazil 76
10 MIDDLE EAST AND AFRICA 77
10.1 MIDDLE EAST AND AFRICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY TYPE 78
10.2 MIDDLE EAST AND AFRICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION 79
10.3 MIDDLE EAST AND AFRICA THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY COUNTRIES 80
10.3.1 Middle East and Africa Thyroid Gland Disorders Treatment Sales by Countries 80
10.3.2 Middle East and Africa Thyroid Gland Disorders Treatment Revenue by Countries 81
10.3.3 Middle East 82
10.3.4 Africa 83
11 COMPANY PROFILES 85
11.1 ABBVIE 85
11.1.1 Company Profile 85
11.1.2 Product Information 86
11.1.3 Sales, Price, Revenue, Gross Margin and Market Share 87
11.2 MERCK KGAA 87
11.2.1 Company Profile 87
11.2.2 Product Information 88
11.2.3 Sales, Price, Revenue, Gross Margin and Market Share 89
11.3 LANNETT COMPANY 89
11.3.1 Company Profile 89
11.3.2 Product Information 91
11.3.3 Sales, Price, Revenue, Gross Margin and Market Share 91
11.4 MYLAN 92
11.4.1 Company Profile 92
11.4.2 Product Information 93
11.4.3 Sales, Price, Revenue, Gross Margin and Market Share 94
11.5 ALLERGAN 94
11.5.1 Company Profile 94
11.5.2 Product Information 95
11.5.3 Sales, Price, Revenue, Gross Margin and Market Share 96
11.6 PFIZER 96
11.6.1 Company Profile 96
11.6.2 Product Information 97
11.6.3 Sales, Price, Revenue, Gross Margin and Market Share 98
11.7 NOVARTIS 98
11.7.1 Company Profile 98
11.7.2 Product Information 99
11.7.3 Sales, Price, Revenue, Gross Margin and Market Share 100
11.8 GLAXOSMITHKLINE 100
11.8.1 Company Profile 100
11.8.2 Product Information 102
11.8.3 Sales, Price, Revenue, Gross Margin and Market Share 102
11.9 ABBOTT LABORATORIES 103
11.9.1 Company Profile 103
11.9.2 Product Information 104
11.9.3 Sales, Price, Revenue, Gross Margin and Market Share 104
11.10 SANOFI 105
11.10.1 Company Profile 105
11.10.2 Product Information 106
11.10.3 Sales, Price, Revenue, Gross Margin and Market Share 106
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 107
12.1 VALUE CHAIN ANALYSIS 107
12.2 SALES CHANNELS ANALYSIS 108
12.2.1 Thyroid Gland Disorders Treatment Sales Channels 108
12.2.2 Thyroid Gland Disorders Treatment Distributors 110
12.3 THYROID GLAND DISORDERS TREATMENT CUSTOMERS 112
13 MARKET FORECAST 114
13.1 GLOBAL THYROID GLAND DISORDERS TREATMENT SALES AND REVENUE FORECAST 2019-2025 114
13.2 GLOBAL THYROID GLAND DISORDERS TREATMENT SALES FORECAST BY TYPE 115
13.3 GLOBAL THYROID GLAND DISORDERS TREATMENT SALES FORECAST BY APPLICATION 117
13.4 THYROID GLAND DISORDERS TREATMENT FORECAST BY REGIONS 119
13.4.1 Global Thyroid Gland Disorders Treatment Sales Forecast by Regions2019-2025 119
13.4.2 Global Thyroid Gland Disorders Treatment Revenue Forecast by Regions2019-2025 120
13.5 NORTH AMERICA MARKET FORECAST 122
13.5.1 North America Thyroid Gland Disorders Treatment Forecast by Countries 2019-2025 122
13.5.2 United States 123
13.5.3 Canada 124
13.5.4 Mexico 125
13.6 EUROPE MARKET FORECAST 125
13.6.1 Europe Thyroid Gland Disorders Treatment Forecast by Countries 2019-2025 125
13.6.2 Germany 127
13.6.3 UK 128
13.6.4 France 129
13.6.5 Italy 130
13.6.6 Russia 131
13.7 ASIA PACIFIC MARKET FORECAST 131
13.7.1 Asia Pacific Thyroid Gland Disorders Treatment Sales Forecast by Countries 2019-2025 131
13.7.2 China 133
13.7.3 Japan 134
13.7.4 Korea 135
13.7.5 India 136
13.7.6 Southeast Asia 137
13.8 CENTRAL & SOUTH AMERICA MARKET FORECAST 137
13.8.1 Central & South America Thyroid Gland Disorders Treatment Sales Forecast by Countries 2019-2025 137
13.8.2 Brazil 139
13.8.3 Argentina 139
13.8.4 Columbia 140
13.9 MIDDLE EAST AND AFRICA MARKET FORECAST 140
13.9.1 Middle East and Africa Thyroid Gland Disorders Treatment Sales Forecast by Regions 2019-2025 140
13.9.2 Middle East 141
13.9.3 Africa 142
14 RESEARCH FINDINGS AND CONCLUSION 143
15 APPENDIX 144
15.1 RESEARCH METHODOLOGY 144
15.1.1 Methodology/Research Approach 144
15.1.1.1 Research Programs/Design 144
15.1.1.2 Market Size Estimation 145
15.1.1.3 Market Breakdown and Data Triangulation 146
15.1.2 Data Source 148
15.1.2.1 Secondary Sources 148
15.1.2.2 Primary Sources 149
15.2 AUTHOR DETAILS 150
15.3 DISCLAIMER 151